Brought to you by 
Harpoon Therapeutics nets $75mm via initial public offering
17 Oct 2019
Executive Summary
Harpoon Therapeutics Inc. (cancer immunotherapies) completed its initial public offering, netted $75mm through the sale of 5.77mm common shares (including partial exercise of the overallotment) at $14 (the midpoint of its intended $13-15 range).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com